Results 131 to 140 of about 59,923 (283)

Hyperbilirubinemia: a new diagnostic marker for perpendicular perforation

, 2017
Y. B. Ramaswami, Hariprasath Prakash, Raghavendra Prabhu T. C, Faiyaz Abdul Jabbar   +3 more
openalex   +2 more sources

Neoadjuvant Paclitaxel–Carboplatin Chemotherapy Followed by Cesarean Radical Hysterectomy in Pregnant Patients With Cervical Cancer: Obstetric, Neonatal, and Surgical Outcomes

Journal of Obstetrics and Gynaecology Research, Volume 52, Issue 8, August 2026.
ABSTRACT Objective To evaluate pregnancy, peripartum, neonatal, and oncologic outcomes in pregnant patients with cervical cancer treated with neoadjuvant paclitaxel–carboplatin chemotherapy followed by cesarean radical hysterectomy (CRH). Methods This retrospective single‐center study included nine pregnant women diagnosed with histologically confirmed
Ok‐Ju Kang, Ji‐Hye Koh, Shin‐Wha Lee, Jeoung‐Yeol Park, Mi‐Young Lee, Jin Hoon Chung, Hye‐Sung Won, Dae‐Yeon Kim   +7 more
wiley   +1 more source

The Role of Gut Microbiota in Liver Regeneration After Partial Hepatectomy: New Evidence From Animal and Human Studies

The FASEB Journal, Volume 40, Issue 14, 31 July 2026.
Partial hepatectomy (PH) reshapes gut microbiota composition, resulting in the release of microbial metabolites and components, including short chain fatty acids (SCFAs)/β‐hydroxybutyric acid (BHB), bacterial DNA and extracellular vesicles (EVs), bile acids (deoxycholic acid, DCA), and aminobenzoate degradation products.
Roberto Loi, Gabriella Simbula, Andrea Caddeo, Monica Pibiri   +3 more
wiley   +1 more source

Prevalence and correlates of hyperbilirubinemia among people living with HIV (PLHIV) receiving atazanavir boosted with ritonavir (ATV/r)

BMC Gastroenterology
Background One of the recommended protease inhibitor treatments for HIV is Atazanavir boosted with Ritonavir (ATV/r). However, hyperbilirubinemia is a well-recognized adverse effect of this therapy.
Hameedreza Farrokhi, Elnaz Shahmohamadi, Ava Pashaei, Hamid Emadi Koochak, Sahar Nooralioghli Parikhani, Masoumeh Fathi Amrollah, Pegah Mirzapour, Seyed Ali Dehghan Manshadi, SeyedAhmad SeyedAlinaghi, Daniel Hackett   +9 more
doaj   +1 more source

Extreme hyperbilirubinemia: An indicator of morbidity and mortality in sickle cell disease

, 2019
John P. Haydek, Cesar Taborda, Rushikesh Shah, Preeti A. Reshamwala, Morgan L. McLemore, Fuad El Rassi, Saurabh Chawla   +6 more
openalex   +1 more source

Nomogram for Acute Bilirubin Encephalopathy Risk in Newborns With Extreme Hyperbilirubinemia [PDF]

, 2020
Yangming Qu, Shuhan Huang, Xin Fu, Youping Wang, Hui Wu   +4 more
openalex   +1 more source

Association between late pregnancy A/G ratio and the risk of neonatal admission for neonatal hyperbilirubinemia [PDF]

Hongjuan Wei, Xin Chang, Rui‐Cheng Ji, Yinyan Tang   +3 more
openalex   +1 more source

Analysis of transient otoacoustic emissions and brainstem evoked auditory potentials in neonates with hyperbilirubinemia [PDF]

, 2009
Daniela Polo Camargo da Silva, Regina Helena Garcia Martins   +1 more
openalex   +1 more source

Standardization of postoperative adverse event reporting: A critical opportunity for improvement within the National Clinical Trials Network

Cancer, Volume 132, Issue 15, 1 August 2026.
Beth Helmink, Matthew H. G. Katz, Chandrajit P. Raut, Sumithra J. Mandrekar, Kristina Laumann, Allison Booth, Laura Hoffman, Eric A. Singer, Isabelle Bedrosian, Rebecca A. Snyder   +9 more
wiley   +1 more source

Incidence and predictors of neonatal hyperbilirubinemia requiring phototherapy: A prospective cohort study at a tertiary hospital in Uganda. [PDF]

PLoS One
Yusuf HM, Turyasiima M, Nankunda J, Twesigemukama SW, Egesa WI, Abdulle AM, Elfakey W, Said ZA, Mohamud AH, Epuitai J, Kahie FD, Hassan HA, Abdi AA, Hakizimana T, Hirsi AM, Nduwimana M.   +15 more
europepmc   +1 more source